Skip to main content

Pheburane® – An innovative approach for effective therapy

Pheburane® marks a new step in the treatment of urea cycle disorders, a rare but serious genetic disease. The drug offers sodium phenylbutyrate in a novel water-based and patient-friendly dosage form to improve utilisation and compliance in patients of all ages.

The relevance of Pheburane® in the modern treatment of urea cycle disorders is high due to the potential for severe metabolic crises. There is still a significant challenge in medical care. The new innovative formulation expands therapeutic options and offers new flavour options that may be critical in the management of this complex disease.

Learn more about Pheburane®

For more information on Pheburane®, including its use, dosage and patient experience, please visit our website at www.pheburane.de.